The race for a vaccine: The investment trust managers combating coronavirus

Outlooks for the biotech sector

clock • 6 min read

With vast swathes of the world in lockdown, the one question on everyone's minds is how long will it take to develop a vaccine against Covid-19?

The Association of Investment Companies (AIC) spoke to investment company and VCT managers about the prospects for a vaccine and how their portfolio companies are contributing to the fight against coronavirus. What are the prospects for a vaccine? Paul Major, Manager of BB Healthcare trust: "We are optimistic that a vaccine will be in commercial production within 18 months. There are more than 40 companies and groups working on a variety of approaches and we are mindful of the swine flu pandemic of 2009, when a vaccine was delivered within around six months from the WHO declaring it an...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now


Already an Investment Week


More on Investment Trusts